title: Cerebral, renal, adrenal, intestinal, and pancreatic circulation in conscious ponies and during 1.0, 1.5, and 2.0 minimal alveolar concentrations of halothane-O2 anesthesia.
abstract: Blood flow to the brain, kidneys, adrenal glands, pancreas, and small intestine was studied in 8 healthy ponies while awake (control) and during 1.0, 1.5, and 2.0 minimal alveolar concentrations (MAC) of anesthesia produced, using halothane vaporized in oxygen. During the anesthesia steps, intermittent positive-pressure ventilation was used to ensure isocapnia. Organ blood flow was determined with 15-micron (diameter) radionuclide-labeled microspheres, after allowing 30 minutes of equilibration at each of the 3 preestablished end-tidal halothane concentrations. The sequence of 1.0, 1.5, and 2.0 MAC levels of anesthesia (0.90, 1.35, and 1.80% end-tidal halothane) was randomized for every animal. In the awake ponies, cerebral blood flow in the cortical (106 +/- 15 ml/min/100 g) and deep gray (103 +/- 12 ml/min/100 g) matter was approximately 5-fold of that in the white matter (22 +/- 3 ml/min/100 g). In the brain stem, there was a decreasing gradient of blood flow from the cranial (thalamohypothalamus: 65 +/- 8 ml/min/100 g) to caudal regions (medulla: 34 +/- 5 ml/min/100 g). Vasodilatation occurred in all regions of the brain with halothane-O2 anesthesia; the decrease in vascular resistance reached its nadir at 1.5 MAC. In the medulla and pons, blood flow increased above control values, with each of the 3 concentrations of halothane, but in the midbrain and thalamohypothalamus, it remained similar to the control value. In the cerebral white matter and cerebellum, blood flow increased with 1.0 and 1.5 MAC of halothane anesthesia, whereas mean aortic pressure decreased to 91% and 74% of the control value. Blood flow in the cerebral cortex was not different from the control value, even at 2.0 MAC of halothane, despite a 49% reduction in perfusion pressure.(ABSTRACT TRUNCATED AT 250 WORDS)
mesh_terms: D000311:Adrenal Glands / Q000098:blood supply; D000758:Anesthesia / Q000009:adverse effects / Q000662:veterinary*; D000818:Animals; D002560:Cerebrovascular Circulation / Q000187:drug effects; D005260:Female; D006221:Halothane / Q000009:adverse effects*; D006439:Hemodynamics / Q000187:drug effects*; D006736:Horses / Q000502:physiology*; D007422:Intestines / Q000098:blood supply; D008297:Male; D010179:Pancreas / Q000098:blood supply; D012039:Regional Blood Flow / Q000187:drug effects; D012079:Renal Circulation / Q000187:drug effects; D014661:Vasoconstriction / Q000187:drug effects; D014664:Vasodilation / Q000187:drug effects
chemical_list: D006221:Halothane